BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8602185)

  • 41. Priorities in health care: reply to Lewis and Charny.
    Lamb D
    J Med Ethics; 1989 Mar; 15(1):33-4. PubMed ID: 11644371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane.
    Sendi PP; Briggs AH
    Health Econ; 2001 Oct; 10(7):675-80. PubMed ID: 11747050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mathematical programming for the efficient allocation of health care resources.
    Stinnett AA; Paltiel AD
    J Health Econ; 1996 Oct; 15(5):641-53. PubMed ID: 10164046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty.
    Sendi P; Al MJ
    Soc Sci Med; 2003 Sep; 57(6):969-74. PubMed ID: 12878098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are pricing and reimbursement decision-making criteria aligned with public preferences regarding allocation principles in the Polish healthcare sector?
    Kolasa K
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):751-62. PubMed ID: 25052370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules.
    O'Brien BJ; Sculpher MJ
    Med Care; 2000 May; 38(5):460-8. PubMed ID: 10800973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clarifying efficiency-equity tradeoffs through explicit criteria, with a focus on developing countries.
    James C; Carrin G; Savedoff W; Hanvoravongchai P
    Health Care Anal; 2005 Mar; 13(1):33-51. PubMed ID: 15889680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Who cares about cost? Does economic analysis impose or reflect social values?
    Nord E; Richardson J; Street A; Kuhse H; Singer P
    Health Policy; 1995 Nov; 34(2):79-94. PubMed ID: 10153484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethics and effectiveness: rationing healthcare by thresholds of minimum effectiveness.
    Buyx AM; Friedrich DR; Schöne-Seifert B
    BMJ; 2011 Jan; 342():d54. PubMed ID: 21242209
    [No Abstract]   [Full Text] [Related]  

  • 50. Cost-effective management of colon and rectal cancer.
    Heine JA; Rothenberger DA
    World J Surg; 1991; 15(5):597-604. PubMed ID: 1949858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporating equity in regulatory and benefit-cost analysis using risk-based preferences.
    Farrow S
    Risk Anal; 2011 Jun; 31(6):902-7. PubMed ID: 20723150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Methods of economic analysis of screening programs. Situation in Czech Republic].
    Bartáková J; Jiskra J
    Vnitr Lek; 2014 Mar; 60(3):212-5. PubMed ID: 24981696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mass screening: theory and ethics.
    Mant D; Fowler G
    BMJ; 1990 Apr; 300(6729):916-8. PubMed ID: 2110841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extrapolation of cost-effectiveness information to local settings.
    Bryan S; Brown J
    J Health Serv Res Policy; 1998 Apr; 3(2):108-12. PubMed ID: 10180659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When drug treatment in the elderly is not cost effective. An ethical dilemma in an environment of healthcare rationing.
    Chadwick R; Levitt M
    Drugs Aging; 1995 Dec; 7(6):416-9. PubMed ID: 8601049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-based rationing in the allocation of health care.
    Dey I; Fraser N
    J Aging Health; 2000 Nov; 12(4):511-37. PubMed ID: 11503730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence.
    Laska EM; Meisner M; Siegel C; Stinnett AA
    Health Econ; 1999 Mar; 8(2):171-4. PubMed ID: 10342730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Good policy, good process.
    Ells C
    Am J Bioeth; 2001; 1(2):34-5. PubMed ID: 11951882
    [No Abstract]   [Full Text] [Related]  

  • 59. Risky decision making and allocation of resources for leukemia and AIDS programs.
    Levin IP; Chapman DP
    Health Psychol; 1993 Mar; 12(2):110-7. PubMed ID: 8500437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The interpretation of results of economic evaluation: explicating the value of health.
    Ament A; Baltussen R
    Health Econ; 1997; 6(6):625-35. PubMed ID: 9466144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.